-
Association between SLCO1B1, apolipoprotein E and ABCG2 genes and lipid response to rosuvastatin: a meta-analysi
Author: Li, Jianhai; Deng, Yongkun; Lai, Yong; Li, Lei; Yu, Limei; Li, Huiyou; Yin, Zhaohen; Liu, Lingyan
Journal: PHARMACOGENETICS AND GENOMICS. 2026; Vol. 36, Issue 3, pp. 88-97. DOI: 10.1097/FPC.0000000000000592
-
Assessment of the potential impact of polymorphisms in the Foxp3 and CTLA-4 genes in immune balance and disease susceptibility of primary Sjögren's syndrom
Author: Feng, Min; Meng, Fanxing; Wang, Yanlin; Jia, Yuhan; Ji, Guozhen; Jin, Yue; Gao, Chong; Luo, Jing
Journal: PHARMACOGENETICS AND GENOMICS. 2025; Vol. 35, Issue 5, pp. 159-169. DOI: 10.1097/FPC.0000000000000567
-
The impact of genetic variations in FPGS, MTHFR, and ATIC on methotrexate response among pediatric patients with acute lymphoblastic leukemi
Author: Wang, Shu-Mei; Zhao, Dan-Qi; Kong, Xiao-Yan; Li, Miao
Journal: PHARMACOGENETICS AND GENOMICS. 2025; Vol. 35, Issue 4, pp. 127-135. DOI: 10.1097/FPC.0000000000000563
-
Global Investigation of Clinical Implementation Strategies for DPYD and UGT1A1 Pharmacogenetic Testing to Guide Anticancer Therap
Author: El Rouby, Nihal; Ali, Muhammad Sarfraz; Aquilante, Christina; Bargal, Salma; Cavallari, Larisa; Duarte, Julio; Mazhindu, Tinashe; Nagy, Mohamed; Nie, Xiaoyan; Nguyen, Grace; Skaar, Todd Skaar; Smith, D. Max; Tuteja, Sony; Van Schiak, Ron; Hicks, J. Kevin
Journal: PHARMACOGENETICS AND GENOMICS. 2025; Vol. 35, Issue 1, pp. 30-31. DOI:
